Generali Asset Management SPA SGR acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 10,691 shares of the semiconductor company's stock, valued at approximately $5,189,000.
Several other large investors have also recently bought and sold shares of the company. Kieckhefer Group LLC acquired a new position in shares of Synopsys in the 4th quarter valued at $27,000. Whipplewood Advisors LLC acquired a new position in Synopsys in the fourth quarter valued at about $33,000. Sierra Ocean LLC bought a new stake in shares of Synopsys in the fourth quarter worth about $39,000. Newbridge Financial Services Group Inc. bought a new stake in shares of Synopsys in the fourth quarter worth about $51,000. Finally, Versant Capital Management Inc lifted its holdings in shares of Synopsys by 109.3% during the 4th quarter. Versant Capital Management Inc now owns 113 shares of the semiconductor company's stock valued at $55,000 after purchasing an additional 59 shares in the last quarter. Institutional investors own 85.47% of the company's stock.
Insiders Place Their Bets
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the transaction, the chief executive officer now owns 70,922 shares of the company's stock, valued at $32,890,077.50. The trade was a 13.81 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CRO Richard S. Mahoney sold 20,838 shares of the firm's stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the sale, the executive now directly owns 1,460 shares of the company's stock, valued at approximately $738,774.60. The trade was a 93.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 47,909 shares of company stock valued at $22,794,835. 0.62% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
SNPS has been the subject of a number of research reports. Redburn Atlantic started coverage on Synopsys in a research note on Monday, January 13th. They set a "buy" rating and a $600.00 target price for the company. Piper Sandler dropped their price objective on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Morgan Stanley cut their price objective on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a research report on Monday, February 24th. Rosenblatt Securities reissued a "buy" rating and issued a $660.00 price target on shares of Synopsys in a research note on Tuesday, February 25th. Finally, Robert W. Baird reduced their price objective on Synopsys from $644.00 to $630.00 and set an "outperform" rating for the company in a research report on Thursday, December 5th. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $638.58.
View Our Latest Report on SNPS
Synopsys Trading Down 0.3 %
Shares of Synopsys stock traded down $1.39 on Friday, reaching $448.60. 3,362,089 shares of the company were exchanged, compared to its average volume of 1,020,823. Synopsys, Inc. has a one year low of $425.73 and a one year high of $624.80. The company has a 50-day moving average of $491.19 and a 200 day moving average of $506.23. The company has a market capitalization of $69.36 billion, a price-to-earnings ratio of 30.90, a PEG ratio of 3.23 and a beta of 1.16.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.